Reassessing Empirical Use of Vancomycin in Pediatric Patients in Areas with Low MRSA Incidence: A Study of Necessity and Overprescription

• by Phuwakrit Nithirungruang, Chonnamet Techasaensiri, Sophida Boonsathorn, Sujittra Chaisavaneeyakorn, Nopporn Apiwattanakul

• January 28, 2026

Letter to perpetual observational study of the clinical and microbiological epidemiology of ventilator-associated pneumonia in Europe

• by Ignacio Martin-Loeches, Luis Felipe Reyes

• April 9, 2026

Top 10 evidence-based essentials in infectious disease

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

• by MDSpire News Staff

• August 18, 2026

• 4 min

Pharmacokinetic Profile of Dalbavancin in Complicated Bacteremia Caused by Staphylococcus aureus: A Secondary Analysis

• by Thomas P. Lodise, Nicholas A. Turner, Toshimitsu Hamasaki, Nick Fishbane, Varduhi Ghazaryan, Alison Wall, Lizhao Ge, Qihang Wu, Lijuan Zeng, Todd Riccobene, Rinal Patel, Smitha Zaharoff, Urania Rappo, Scott Evans, Vance G. Fowler, Henry F. Chambers, Thomas L. Holland, Antibacterial Resistance Leadership Group, Robin Patel, Heather Cross, Anthony Harris, Melinda Pettigrew, David van Duin, Helen Boucher, Clayton Huntley, Erica Raterman, Tamika Samuel, Kyung Moon, Kim Hanson, Yohei Doi, Tom Lodise, Ritu Banerjee, Sara Cosgrove, David Paterson, Ebbing Lautenbach, Maureen Mehigan, Sarah Doernberg, Sam Perdue

• April 18, 2026